Life Sciences Archive » December, 2008

Life Sciences - December, 2008

139 articles

• Int'l Plaintiffs Appeal Dismissal From Aredia MDL
• Doctor To Back Off Drug Trials Amid Ethics Probe
• CORRECTION: Actavis To Halt Production At 3 Plants
• Role Of Rule 10b5-1 Plans In Securities Litigation
• Judge OKs Class In K-Dur Reverse-Payment Suit
• FTC OKs $1.6B King, Alpharma Deal With Divestiture
• Hemispherx Suit Over Merger Attempt Resuscitated
• Injunction Affirmed In Stryker Screw Patent Case
• Bayer Hits Abbott With Patent Suit Over Humira
• Abbott's Humira Ad Makes Unsupported Claims: FDA
• Abbott Loses Bid To Erase $29M In Damages
• 9 Defendants Dismissed From Prempro Suits
• Lilly Clashes With Valeant Over Permax Liability Costs
• Bristol-Myers, States Settle Plavix Case For $1.1M
• Fearing Oversize Pills, KV Freezes Pill Shipments
• Dr. Reddy's Eyes 2012 Launch Of Generic Clarinex
• Forest's $65M Settlement Over Antidepressants OK'd
• Drug Cos. Settle Chewable Contraceptive Patent Suit
• FDA Issues Top Recall For Stryker Cranial Implants
• Teva Agrees To Sell Assets In $8.9B Merger With Barr
• Pfizer Ordered To Pay $39M In Trade Secrets Dispute
• NFL Appeals Injunction In Players' Suit Over Diet Pills
• MedImmune Targets 5 PDL Patents In Licensing Spat
• Judge Tosses Protein Patent Suit Against Genentech
• NJ Supreme Court Axes 'Super Lawyer' Ad Ban
• Shareholders Sue Mentor Over $1B Merger With J&J
• Despite Statute, Rite Aid Worker Can Sue: Judge
• Fed. Circ. Remands Guidant Patent Case For Damages
• Mentor Prevails In 1st ObTape Product Liability Trial
• Damages Reduced In Cardinal's $12.2M Suit V. Tyco
• Antitrust, Infringement Claims Split In Cardizem Suit
• FDA Orders Suicide Warnings On Epilepsy Drugs
• AstraZeneca To Add Defendant In Nexium Patent Suit
• Fired Amgen Lawyer Can Pursue Case In Court
• Meijer Reaches $13M Deal With Barr In Ovcon Case
• Increasing Antitrust Enforcement Under Obama?
• Lupin Settles Clarinex Suit With Schering
• Judge Refuses To Toss Class Claim In FedEx MDL
• Eli Lilly Continues Crusade Against Cymbalta Generics
• Fed. Circ. Issues Mixed Ruling In Apnea Patent Case
• Orchid Counters Roche Claims In Boniva Patent Suit
• CIBA Drags More J&J Products Into Lens Patent Spat
• Gilead Sues Teva Over Truvada ANDA
• Bayer To Pay $18.5M To Settle Baycol Securities MDL
• Ovation Hiked Drug Price Almost 1,300 Percent: FTC
• Apotex Adds New Patent Challenge In Boniva Dispute
• Schering Sues Orchid In Latest Clarinex Patent Suit
• 4th Circ. Upholds Dismissal Of Inspire Securities Suit
• St. Jude Hit With Patent Suit Over Pacemaker
• Glaxo's Zinc-Containing Denture Cream Unsafe: Suit
• Direct Buyers Seek Class Certification In Flonase Suit
• Additional Patent Term Adjustment Under Wyeth
• High Court OKs Use Of State Laws In Tobacco Suits
• IP Practice: Paul Hastings
• Senator Demands Details On Wyeth Journal Articles
• Fed. Circ. Upholds Validity Of Sanofi's Plavix Patent
• Healon D Maker Recalls Drug Over Inflammatory Toxin
• Takeda V. Mylan — Keeping Your Ducks In A Row
• Medtronic To Report Death Of InFuse User To FDA
• Wound VAC Patent Suit V. Smith & Nephew Expands
• FDA Weighs Lilly, Amgen Findings On Cancer Drugs
• Injunction Extended in NFL Players' Suit Over Pills
• Medtronic Hit With Securities Suit Over InFuse Sales
• Drug Industry Boosts Consumer Marketing Rules
• Perrigo, Sepracor Settle Clarinex Patent Suit
• Warning Irrelevant In Zocor Case V. Merck: 9th Circ.
• Fed. Circ., KSR and Pharmas: The First Year And A Half
• Merck Fails To Force Trial Of Bellwether Fosamax Case
• Texas Appeals Court Makes U-Turn In Vioxx Case
• Bowel Cleansers To Get Black Box Warning: FDA
• No Causation In Human Tissue MDL: Judge
• Top 10 ITC Developments For 2008
• Teva, Pfizer Both Score Wins In Detrol Patent Fight
• Bayer Gets Another Suit Dropped In Baycol MDL
• WL Gore Loses Bid To Invalidate Medtronic Patents
• AstraZeneca Fires 3rd Suit At Handa Over Seroquel
• Ramifications Of The Net MoneyIN Inc. Decision
• Orion Continues Patent Battle Against Generic Stalevo
• 2nd Circ. Upholds 3.5-Year Term For Ex-Impath Exec
• WFN To Stop Touting 'Disease-Fighting' Supplements
• Former Heller Antitrust Veteran Joins White & Case
• Hospira Recalls Potassium Chloride Over Mislabeling
• Class Action Over Pepsi Bottled Water Dismissed
• Morgan Lewis Snaps Up Seasoned Litigator
• The Grim Outlook For Business Method Patents
• Employment Practice: Paul Hastings
• 60,000 Bottles Added To StarCaps Diet Pill Recall
• Regulators Hit With $110M Suit Over Fluoride Pills
• Plaintiff Seeks To Revive FCA Suit V. Express Scripts
• Medtronic Willfully Infringed Disc Patent: Jury
• King Sues Sandoz Over Patent For Muscle Relaxant
• Fired Roche Worker Files Sexual Harassment Suit
• Device For Cardiac Bypass In Children Recalled
• Fed. Circ. Upholds $16.8M Fees Award For Takeda
• Negligence Claim On Foley's Tardy Filing Remains
• Leaps & Bounds: Notable Firm News
• Cases Mount Against Mentor Over Vaginal Implant
• Eli Lilly Fires Off Another Cymbalta Patent Suit
• KV Adds Sherman Act Counterclaims To Ritalin Suit
• Auxilium Sues Upsher-Smith Over Testim ANDA
• Roche, Dr. Reddy's Drop One Patent In Boniva Suit
• Johnson & Johnson In-House Counsel Joins Lovells
• Appeals Court Grills Patent Office Over Rules
• Judge Won't Enforce $100K Deal In Liver Failure Case
• Health Food Co. Selling Unauthorized Drugs: FDA Suit
• Skadden Takes Clifford Chance White Collar Trio
• J&J, CIBA To Head To Trial Over Contact Lens Patent
• Court Denies UK Agency's Appeal In Price-Fixing Spat
• Bayer May Face Canadian Class Action Over Trasylol
• Recalls, Investigation Result In KV Investors' Suit
• On The Docket: IP Cases To Follow In 2009
• Ohio Supreme Court Rules On Workers' Comp Claims
• How To Woo In-House Counsel In A Recession
• Health Cases To Watch In 2009
• Lupin Challenges Oscient's Cholesterol Drug Patent
• Biogen Sues USPTO Over Patent Term Adjustment
• Innohep Possibly Unsafe For Elderly Patients: FDA
• Competition Cases To Watch In 2009
• Medtronic's Bone Graft Product Caused Death: Suit
• USPTO Appeals Wyeth Patent Term Adjustment Ruling
• Molecular Insight Hits USPTO Over Patent Terms
• Glenmark Lobs Counterclaims At Teva In Coreg Suit
• Mylan, Novartis Settle Spat Over Femara Generic
• EU Extends Inspection Of Teva-Barr Deal
• Solvay Sues USPTO Over Refusal To Extend Patent
• Impax, Medicis Clear Up Acne Patent Dispute
• Ky. High Court Upholds $7.8M Verdict In Parlodel Suit
• Life Sciences Brace For Aftermath Of Bilski
• Cutera Securities Plaintiffs Plot Appeal
• NY AG Honcho Moves To Labaton Sucharow
• Leiner Seeks To Buy Time To Appease IRS, Buyer
• Vulnerability Or Validity: Which Standard Is Correct?
• Zimmer Wins Summary Judgment In Implant Suit
• Is A Substantial Question Of Validity Enough?
• EU Attack On Drug IP Practices Presents Challenges
• In Pharma Cases, Injunctions Are In Public Interest
• Despite Melamine, Infant Formula Safe: FDA
• Plaintiff Granted Dismissal In Chantix Class Action
• Obama, Holder Hint At Justice Priorities